---
schema_version: "secwatch.filing_event.v1"
accession: "0001779128-23-000007"
form_type: "8-K"
ticker: "SRTA"
cik: "0001779128"
company_name: "Strata Critical Medical, Inc."
filed_at: "2023-01-10T23:59:59+00:00"
generated_at: "2026-06-20T17:12:51.682420+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Blade revenue jumps to $24.6M in transition period; net income positive on warrant gain

## Summary
- Revenue $24.6M for three months ended Dec 31, 2021, up from $8.0M in prior-year period.
- Operating loss widened to $10.5M from $2.4M; net income $0.8M includes $10.9M non-cash warrant gain.
- Cash and short-term investments total $282M at Dec 31, 2021; cash used in ops $6.0M.
- Acquired exclusive rights to Helijet’s scheduled Canadian passenger routes for $12.4M during period.
- Fiscal year changed from Sept 30 to Dec 31; audited transition-period financials filed.

## SEC filing metadata
- accession: 0001779128-23-000007
- form_type: 8-K
- ticker: SRTA
- cik: 0001779128
- company_name: Strata Critical Medical, Inc.
- filed_at: 2023-01-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779128/000177912823000007/0001779128-23-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779128/000177912823000007/blde-20230110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001779128-23-000007
- JSON: https://secwatch.observer/filing/0001779128-23-000007.json
- Plain text: https://secwatch.observer/filing/0001779128-23-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.